IAN T. BOTHWELL - 19 Aug 2022 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian T. Bothwell
Issuer symbol
OCEL
Transactions as of
19 Aug 2022
Net transactions value
$0
Form type
4
Filing time
24 Aug 2022, 16:53:18 UTC
Previous filing
02 Nov 2021
Next filing
15 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCEL Warrant to purchase Common Stock Award +30,000,000 30,000,000 19 Aug 2022 Common Stock 30,000,000 $0.0200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Warrants were issued to the Reporting Person in consideration of the Reporting Person having agreed with the Issuer to waive payment of certain accrued but unpaid compensation due him as of July 31, 2022 pursuant to his employment agreement with the Issuer.